| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,000 | $22.50 | $22,504.50 | -4.2% | -9.7% | +38.7% | |
| Mar 19, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,500 | $20.61 | $257,575.00 | -1.2% | +4.4% | +43.8% | |
| Mar 17, 2025 | Kintz Samuel51 | President And CEO | Sell | 12,500 | $20.83 | $260,320.00 | -1.2% | +9.7% | +32.1% | |
| Mar 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $21.44 | $142,936.48 | -2.0% | +1.8% | +40.2% | |
| Feb 27, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $20.41 | $66,326.98 | -20.0% | -20.2% | +47.3% | |
| Feb 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $21.93 | $146,205.98 | -2.0% | -15.3% | +33.7% | |
| Feb 5, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,000 | $22.52 | $22,524.40 | -7.1% | -13.5% | +18.6% | |
| Jan 27, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $21.59 | $70,177.90 | -20.0% | -11.2% | +22.9% | |
| Jan 7, 2025 | Patel Anish54 | Chief Operating Officer | Sale+OE | 28,367 | $24.18 | $685,868.44 | -4.0% | -25.1% | -35.2% | |
| Jan 3, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,000 | $25.04 | $25,038.60 | -7.1% | -18.0% | -36.4% |